Cargando…
CT-Guided Coeliac Plexus Neurolysis in Patients with Intra-Abdominal Malignancy: A Retrospective Evaluation of 52 Palliative In-Patients
INTRODUCTION: Prevalence rates of chronic abdominal pain (CAP) and breakthrough cancer pain (BTcP) are high in patients with intra-abdominal malignancies. As part of a multimodal approach, CT-guided coeliac plexus blockade (CPB) and CT-guided coeliac plexus neurolysis (CPN) are commonly used pain ma...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586091/ https://www.ncbi.nlm.nih.gov/pubmed/34546553 http://dx.doi.org/10.1007/s40122-021-00317-1 |
_version_ | 1784597824337346560 |
---|---|
author | Neuwersch-Sommeregger, Stefan Köstenberger, Markus Stettner, Haro Pipam, Wofgang Breschan, Christian Feigl, Georg Likar, Rudolf Egger, Markus |
author_facet | Neuwersch-Sommeregger, Stefan Köstenberger, Markus Stettner, Haro Pipam, Wofgang Breschan, Christian Feigl, Georg Likar, Rudolf Egger, Markus |
author_sort | Neuwersch-Sommeregger, Stefan |
collection | PubMed |
description | INTRODUCTION: Prevalence rates of chronic abdominal pain (CAP) and breakthrough cancer pain (BTcP) are high in patients with intra-abdominal malignancies. As part of a multimodal approach, CT-guided coeliac plexus blockade (CPB) and CT-guided coeliac plexus neurolysis (CPN) are commonly used pain management strategies. The aim of this study was to evaluate pain outcomes among patients with intra-abdominal malignancies who underwent CPB and/or CPN. METHODS: Patients with intra-abdominal malignancies who underwent CPB and/or CPN for pain control at the general hospital Klagenfurt am Wörthersee from 2010 to 2019 were enrolled. RESULTS: A total of 84 procedures (24 CPB and 60 CPN) were performed on 52 patients; 62% of these patients had pancreatic cancer. CPN led to significant pain reduction and decreased BTcP intensity. Patients receiving repeated CPN showed higher individual pain reduction. Higher pre-procedural pain intensity was correlated with higher pain reduction. No difference in pain reduction in patients receiving a diagnostic CPB prior to CPN compared to patients without a diagnostic CPB was found. Higher pain reduction after CPN led to longer-lasting pain relief. The time frame from diagnosis to CPN was 472 (± 416) days. Patients experienced a mean duration of pain prior to CPN of 330 (± 53) days. The time frame from diagnosis to CPN was shorter in patients with pancreatic cancer compared to other intra-abdominal malignancies. In 58% of patients pain medication was stable or was reduced after CPN; 16% of patients complained about pain during the procedure; no major complications occurred. There was no correlation between median survival after CPN and pain outcomes. CONCLUSIONS: In patients with intra-abdominal malignancy-related CAP, CPN is a safe and effective procedure which can provide long-lasting significant relief of background pain and BTcP. As part of a multimodal approach, CPN should be considered as an earlier option for pain management in these patients. |
format | Online Article Text |
id | pubmed-8586091 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-85860912021-11-15 CT-Guided Coeliac Plexus Neurolysis in Patients with Intra-Abdominal Malignancy: A Retrospective Evaluation of 52 Palliative In-Patients Neuwersch-Sommeregger, Stefan Köstenberger, Markus Stettner, Haro Pipam, Wofgang Breschan, Christian Feigl, Georg Likar, Rudolf Egger, Markus Pain Ther Original Research INTRODUCTION: Prevalence rates of chronic abdominal pain (CAP) and breakthrough cancer pain (BTcP) are high in patients with intra-abdominal malignancies. As part of a multimodal approach, CT-guided coeliac plexus blockade (CPB) and CT-guided coeliac plexus neurolysis (CPN) are commonly used pain management strategies. The aim of this study was to evaluate pain outcomes among patients with intra-abdominal malignancies who underwent CPB and/or CPN. METHODS: Patients with intra-abdominal malignancies who underwent CPB and/or CPN for pain control at the general hospital Klagenfurt am Wörthersee from 2010 to 2019 were enrolled. RESULTS: A total of 84 procedures (24 CPB and 60 CPN) were performed on 52 patients; 62% of these patients had pancreatic cancer. CPN led to significant pain reduction and decreased BTcP intensity. Patients receiving repeated CPN showed higher individual pain reduction. Higher pre-procedural pain intensity was correlated with higher pain reduction. No difference in pain reduction in patients receiving a diagnostic CPB prior to CPN compared to patients without a diagnostic CPB was found. Higher pain reduction after CPN led to longer-lasting pain relief. The time frame from diagnosis to CPN was 472 (± 416) days. Patients experienced a mean duration of pain prior to CPN of 330 (± 53) days. The time frame from diagnosis to CPN was shorter in patients with pancreatic cancer compared to other intra-abdominal malignancies. In 58% of patients pain medication was stable or was reduced after CPN; 16% of patients complained about pain during the procedure; no major complications occurred. There was no correlation between median survival after CPN and pain outcomes. CONCLUSIONS: In patients with intra-abdominal malignancy-related CAP, CPN is a safe and effective procedure which can provide long-lasting significant relief of background pain and BTcP. As part of a multimodal approach, CPN should be considered as an earlier option for pain management in these patients. Springer Healthcare 2021-09-21 2021-12 /pmc/articles/PMC8586091/ /pubmed/34546553 http://dx.doi.org/10.1007/s40122-021-00317-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Original Research Neuwersch-Sommeregger, Stefan Köstenberger, Markus Stettner, Haro Pipam, Wofgang Breschan, Christian Feigl, Georg Likar, Rudolf Egger, Markus CT-Guided Coeliac Plexus Neurolysis in Patients with Intra-Abdominal Malignancy: A Retrospective Evaluation of 52 Palliative In-Patients |
title | CT-Guided Coeliac Plexus Neurolysis in Patients with Intra-Abdominal Malignancy: A Retrospective Evaluation of 52 Palliative In-Patients |
title_full | CT-Guided Coeliac Plexus Neurolysis in Patients with Intra-Abdominal Malignancy: A Retrospective Evaluation of 52 Palliative In-Patients |
title_fullStr | CT-Guided Coeliac Plexus Neurolysis in Patients with Intra-Abdominal Malignancy: A Retrospective Evaluation of 52 Palliative In-Patients |
title_full_unstemmed | CT-Guided Coeliac Plexus Neurolysis in Patients with Intra-Abdominal Malignancy: A Retrospective Evaluation of 52 Palliative In-Patients |
title_short | CT-Guided Coeliac Plexus Neurolysis in Patients with Intra-Abdominal Malignancy: A Retrospective Evaluation of 52 Palliative In-Patients |
title_sort | ct-guided coeliac plexus neurolysis in patients with intra-abdominal malignancy: a retrospective evaluation of 52 palliative in-patients |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586091/ https://www.ncbi.nlm.nih.gov/pubmed/34546553 http://dx.doi.org/10.1007/s40122-021-00317-1 |
work_keys_str_mv | AT neuwerschsommereggerstefan ctguidedcoeliacplexusneurolysisinpatientswithintraabdominalmalignancyaretrospectiveevaluationof52palliativeinpatients AT kostenbergermarkus ctguidedcoeliacplexusneurolysisinpatientswithintraabdominalmalignancyaretrospectiveevaluationof52palliativeinpatients AT stettnerharo ctguidedcoeliacplexusneurolysisinpatientswithintraabdominalmalignancyaretrospectiveevaluationof52palliativeinpatients AT pipamwofgang ctguidedcoeliacplexusneurolysisinpatientswithintraabdominalmalignancyaretrospectiveevaluationof52palliativeinpatients AT breschanchristian ctguidedcoeliacplexusneurolysisinpatientswithintraabdominalmalignancyaretrospectiveevaluationof52palliativeinpatients AT feiglgeorg ctguidedcoeliacplexusneurolysisinpatientswithintraabdominalmalignancyaretrospectiveevaluationof52palliativeinpatients AT likarrudolf ctguidedcoeliacplexusneurolysisinpatientswithintraabdominalmalignancyaretrospectiveevaluationof52palliativeinpatients AT eggermarkus ctguidedcoeliacplexusneurolysisinpatientswithintraabdominalmalignancyaretrospectiveevaluationof52palliativeinpatients |